MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias

Leukemia and Lymphoma

Volumn 56, Issue 5, 2015, Pages 1466-1474

  Testa, Ugo ^a   Pelosi, Elvira ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Basic biology; Myeloid leukemias and dysplasias; Stem and primitive progenitor cells

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 125; MICRORNA 125A; MICRORNA 125B; MICRORNA 126; MICRORNA 130A; MICRORNA 155; MICRORNA 155P; MICRORNA 181A; MICRORNA 191; MICRORNA 196B; MICRORNA 203; MICRORNA 20B; MICRORNA 213; MICRORNA 214; MICRORNA 22; MICRORNA 223; MICRORNA 25; MICRORNA 26B; MICRORNA 29; MICRORNA 34A; MICRORNA 363; MICRORNA 517C; MICRORNA 518A; MICRORNA 519D; MICRORNA 520H; MICRORNA 545; MICRORNA 548D; MICRORNA 99A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 21; CHROMOSOME 9; DNA METHYLATION; DOWN REGULATION; ERYTHROID PRECURSOR CELL; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN GENOME; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; ONCOGENE C MYC; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RNA INTERFERENCE;

CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; RNA INTERFERENCE;

EID: 84932155347     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.955019     Document Type: Article

References (72)

1. Doulatov S, Notta F, Eppert K, et al. Revised map of the human progenitors hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010; 11: 585-593.
2. Gorgens A, Radtke S, Mollmann M, et al. Revision of the human hematopoietic tree:granulocytes subtypes derive from distinct hematopoietic lineages. Cell Rep 2013; 3: 1539-1552.
3. Notta F, Doulatov S, Laurenti E, et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218-221.
4. Goardon N, Marchi E, Atzerberger A, et al. Coexistence of LMMP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011;19:138-152.
5. Anjos-Afonso F, Currie E, Palmer HG, et al. CD34-cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures. Cell Stem Cell 2013;13:161-174.
6. Yamamoto R, Morita Y, Oehara J, et al. Clonal analysis unveils self-renewing lineage-restricted progenitors directly generated from hematopoietic stem cells. Cell 2013;154:1112-1126.
7. Sanjuan-Pla A, Maculay IC, Jensen CT, et al. Platelet-biased stem cells at the apex of the hematopoietic stem cell hierarchy. Nature 2013;502:232-236.
8. Grover A, Mancini E, Moore S, et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. JExp Med 2014;211:181-188.
9. Marcucci G, Mzorek K, Radmacher M, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 2011;117:1121-1129.
10. Ling H, Fabbri M, Calin G. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discovery 2013;12:847-865.
11. Undi RB, Kandi R, Gutti RK. MicroRNAs as hematopoiesis regulators. Adv Hematol 2013;e 695754.
12. Batmagar B, Garzon R. The use of molecular genetics to ref ne prognosis in acute myeloid leukemia. Curr Hematol Malig Rep 2014;9:148-157.
13. Georgantas R III, Hildreth R, Morisot S, et al. CD34 +hematopoietic stem/progenitor cell microRNA expression and function: a circuit diagram of dif erentiation control. Proc Natl Acad Sci USA 2007;104:2750-2755.
14. O'Connell R, Chaudhuri A, Rao D, et al. MicroRNAs regulate long-term hematopoietic output. Proc Natl Acad Sci USA 2010; 107:14235-14240.
15. Liao R, Sun J, Zhang L, et al. MicroRNA play a role in the development of human hematopoietic stem cells. J Cell Biochem 2008;104:805-817.
16. Merkerova M, Vasikova A, Belickova M, et al. MicroRNA expression prof les in umbilical cord blood lineages. Stem Cell Dev 2010;19:17-25.
17. Jin P, Wang E, Ren J, et al. Dif erentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis. J Transl Med 2008;6:39.
18. Gentner B, Visigalli I, Hiramatsu H, et al. Identif cation of a hematopoietic stem cell-specif c miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med 2010;2:58ra84.
19. Lechman F, Gentner B, van Galen P, et al. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell 2012;11:799-811.
20. Li Z, Lu J, Sun M, et al. Distinct microRNA expression prof les in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008;105:15535-15540.
21. Schurhuis G, Meel M, Wouters F, et al. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic-stem cells. PLoS One 2013;8:e78897.
22. De Leeuw D, Deukers F, Olthof M, et al. Attenuation of microRNA-126 expression that drives CD34 + CD38-stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res 2014;74:2094-2105.
23. Gerrits A, Walasek MA, Olthof S, et al. Genetic screen identif es microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood 2012;119:377-387.
24. Guo S, Lu J, Schlonger R, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci USA 2010; 107:14229-14234.
25. Oboi AG, Sahoo D, Adorno M, et al. Micro-RNA 125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and the lymphoid-biased subsets. Proc Natl Acad Sci USA 2010;107:21505-21510.
26. Bousquet M, Qualen C, Rosati R, et al. Myeloid cell dif erentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008;205:2499-1506.
27. Chaudhury AA, So AY, Mehta A, et al. Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc Natl Acad Sci USA 2012;13;4233-4238.
28. Cheng J, Guo S, Chey S, et al. An extensive network of TET2-targeting microRNAs regulates malignant hematopoiesis. Cell Rep 2013;5:471-481.
29. Klusmann JH, Li Z, Bohmer K, et al. miR-125b-2 is a potential oncomiR on chromosome 21 in megakaryoblastic leukemia. Genes Dev 2010;24:478-490.
30. Song SJ, Ito K, Ala U, et al. The oncogenic microRNA miR-22 targets the TET2-tumor suppressor to promote hematopoietic stem cell-renewal and transformation. Cell Stem Cell 2013;13:87-101.
31. Solary E, Bernard OA, Teferi A, et al. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014;28:485-496.
32. Bissels U, Wild S, Tomiuk S, et al. Combined characterization of microRNA and miRNA prof les delineates early dif erentiation pathways of CD133 + and CD34 + hematopoietic stem-and progenitor cells. Stem Cells 2011;29:847-857.
33. Wang XS, Gong JN, Yu J, et al. MicroRNA-29a and microRNA 142-3p are regulators of myeloid dif erentiation and acute myeloid leukemia. Blood 2012;119:4992-5004.
34. Careccia S, Mainardi S, Pelosi A, et al. A restricted signature distinguishes APL blasts from normal promyelocytes. Oncogene 2009;28:4034-4040.
35. Lu X, Li X, He Q, et al. miR-142-3p regulates the formation and dif erentiation of hematopoietic stem cells in vertebrates. Cell Res 2013;23:1356-1368.
36. Nimmo R, Ciau-Vitz A, Ruiz-Herguido C, et al. miR-142-3p controls the specif cation of def nitive hemangioblasts during ontogeny. Dev Cell 2013;26:237-249.
37. Dahlaus M, Roolf C, Ruck S, et al. Expression and prognostic signif cance of has-miR-142-3p in acute leukemia. Neoplasma 2013;60:432-438.
38. Wang F, Wang XS, Yang GH, et al. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol Biol Rep 2012; 39: 2713-2722.
39. Han JC, Park CY, Bhagat G, et al. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development and acute myeloid leukemia. J Exp Med 2010; 207: 473-489.
40. Gong JN, Yu J, Lin HS, et al. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Cell Death Difer 2014;21:100-112.
41. Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008;111:3183-3189.
42. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945-3950.
43. Garzon R, Heaphy C, Havalange V, et al. MicroRNA-29b functions in acute myeloid leukemia. Blood 2009;114:5331-5341.
44. Liu S, Wu LC, Pang J, et al. Sp1/NFkB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010; 17: 333-347.
45. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene re-expression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009;113:6411-6418.
46. Blum W, Garzon R, Klisovic R, et al. Clinical response and miR-29b predictive signif cance in older AML patients treated with a 10-day schedule of decitabine. Proc Natl Acad Sci USA 2010;107:7473-7478.
47. Blum W, Schwind S, Tarighat S, et al. Clinical and pharmacodynamics activity of bortezomib and decitabine in acute myeloid leukemia. Blood 2012;119:6025-6031.
48. Bernot KM, Nemer JS, Santhanam R, et al. Eradicating acute myeloid leukemia in a MLL (PTD/wt):FLT3 (ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood 2013;122:3778-3783.
49. Mims A, Walker AR, Huang X, et al. Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia 2013; 27: 871-878.
50. Huang X, Schwind S, Yu B, et al. Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res 2013;14:2355-2367.
51. Mintz PJ, Saetram P, Reebye V, et al. MicroRNA-181atargetsNanog in a subpopulation of CD34 + cells isolated from peripheral blood. Mol Ter Nucleic Acids 2012;1:e34.
52. Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 20087;358:1919-1928.
53. Schwind S, Maharry K, Radmacher MD, et al. Prognostic signif cance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2010;28:5257-5264.
54. Li Z, Huang H, Li Y, et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patinets with cytogenetically abnormal AML. Blood 2012; 119: 2314-2324.
55. Hichey C, Schwind S, Radomska A, et al. Lenalidomide-mediated enhanced translation of C/EBPalpha-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood 2013;121:159-169.
56. Senyuk V, Zhang Y, Liu Y, et al. Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis. Proc Natl Acad Sci USA 2013;110:5594-5599.
57. Chen P, Price C, Li Z, et al. miR-9 is an essential oncogenic microRNA specif cally overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA 2013; 110: 11511-11516.
58. Adams B, Guo S, Bai H, et al. An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response. Cell Rep 2012;2:1048-1060.
59. Lu J, Guo S, Ebert BL, et al. Micro RNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008; 14:843-853.
60. Morris VA, Zhang A, Yang T, et al. MicroRNA-150 expression induces myeloid dif erentiation of human acute leukemia cells and normal hematopoietic progenitors. PLoS One 2013;8:e75815.
61. Jang X, Huang H, Li Z, et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell 2012;22:524-535.
62. Bousquet M, Zhuang G, Meng C, et al. miR-150 blocks MLL-AF9-associated leukemia through oncogene repression. Mol Cancer Res 2013;11:912-922.
63. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007;316:608-611.
64. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells cause a myeloproliferative disorder. J Exp Med 2008; 205: 585-594.
65. Forrest AR, Kanamori-Katayama M, Tomaru Y, et al. Induction of microRNAs, miR-155, miR-222, miR-424 and miR-503, promotes monocytic dif erentiation through combinatorial regulation. Leukemia 2010;24:460-466.
66. Faraoni I, Laterza S, Ardiri D, et al. MiR-424 and mIR-155 deregulated expression in cytogenetically normal acute myeloid leukemia: correlation with NPM1 and FLT3 mutation status. J Hematol Oncol 2012;5:26.
67. Jongen-Lavrencic M, Sun SM, Dijkstra MK, et al. MicroRNA expression prof ling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008;111:5078-5085.
68. Cammarata G, Angugliaro L, Salemi D. Dif erential expression of specif c microRNA and their targets in acute myeloid leukemia. Am J Hematol 2010;85:331-339.
69. Wang L, Zhang H, Rodriguez S, et al. Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-kB-dependent manner. Cell Stem Cell 2014;15:51-65.
70. Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY. M icroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci USA 2010;107:21505-21510.
71. Bousquet M, Harris MH, Zhou B, Lodish HF. MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558-21563.
72. Ghani S, Riemke P, Schonheit J, et al. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011;118:2275-2284.